Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00483405
Status:
COMPLETED
Last Update Posted:
2017-07-12
First Post:
2007-06-06
Brief Title:
Oxaliplatin Capecitabine and Cetuximab in Treating Patients With Advanced Liver Cancer
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
UNC Lineberger Comprehensive Cancer Center
Organization Data
Organization:
UNC Lineberger Comprehensive Cancer Center
Class:
OTHER
Study ID:
LCCC 0421
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| Sanofi | INDUSTRY |
| Roche Pharma AG | INDUSTRY |
| Bristol-Myers Squibb | INDUSTRY |
| National Center for Research Resources NCRR | NIH |